Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Supports wound healing and scar remodeling
Safety Across Different Populations The clinical trial program predominantly enrolled individuals with clinical obesity, providing safety data specifically in this population
A Phase 2 trial (Obesity Research, 2004) found 12 weeks of subcutaneous AOD-9604 produced statistically significant abdominal fat reduction versus placebo without altering fasting glucose or insulin levels
Copyright 2026
All of our peptides have gone through rigorous quality control procedures to ensure our clients are receiving the best quality peptides available
The study suggests that BPC 157 may counteract excessive activation or mitigation within these signaling networks
US$ 27.80
US$ 22.24
US$ 27.15
US$ 29.84
